MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours

c-MYC function is associated with specific molecular subtypes of BCs and its overexpression confers resistance to ET. The diverse mechanisms of c-MYC function in the different molecular classes of BCs warrants further investigation particularly as potential therapeutic targets.